TABLE 2.

Demographic and Baseline Characteristics

Omalizumab (n = 18)Placebo (n = 11)P Value
Gender15 males5 males
3 females6 females
Age, y8.8 ± 1.810.8 ± 0.8<.001
Height, cm137.2 ± 14.2145.9 ± 9.1NS
Weight, kg36.2 ± 13.440.8 ± 14.5NS
Serum IgE, IU/mL315.6 ± 279.7301.7 ± 213.0NS
FEV1, mL1665.6 ± 411.22023.6 ± 355.5.02
FEV1, % predicted87.7 ± 15.491.1 ± 14.3NS
FVC, mL2251.7 ± 558.12592.7 ± 376.2NS
Daily BDP dose, μg261.3 ± 114.8282.5 ± 120.4NS
  • Values are mean ± SD. NS indicates not significant; FVC, forced vital capacity.